Article
GSTP1, ERCC1 and ERCC2 polymorphisms, expression and clinical outcome of oxaliplatin-based adjuvant chemotherapy in colorectal cancer in Chinese population.
Asian Pacific journal of cancer prevention : APJCP - 1 Jan 2012
Li Hui-Yan, Ge Xin, Huang Guang-Ming, Li Kai-Yu, Zhao Jing-Quan, Yu Xi-Miao, Bi Wen-Si, Wang Yu-Lin
Abstract excerpt
AIM: Platinum agents have shown to be effective in the treatment of colorectal cancer. We assessed whether single nucleotide polymorphisms (SNPs) in GSTP1, ERCC1 Asn118Asn and ERCC2 Lys751Gln might predict the overall survival in patients receiving oxaliplatin-based chemotherapy in a Chinese popu...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
